SCHEMBL7962456

SCHEMBL7962456

CC(=O)Oc1cccc2c(CNS(=O)(=O)Cc3ccccc3)c(C)oc12

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 2/20 0.41
PKM P14618 1/20 0.41
CA2 P00918 2/20 0.40
HTT P42858 3/20 0.39
NPSR1 Q6W5P4 3/20 0.39
GAA P10253 2/20 0.39
GPR55 Q9Y2T6 1/20 0.39
ADORA3 P0DMS8 1/20 0.38
ADORA2A P29274 1/20 0.38
ADORA1 P30542 1/20 0.38
MCL1 Q07820 1/20 0.37
LMNA P02545 3/20 0.37
HPGD P15428 2/20 0.37
KDM4E B2RXH2 1/20 0.37
ALDH1A1 P00352 1/20 0.37
MPI P34949 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
PTPN1 P18031 1/20 0.37
CYP1A2 P05177 1/20 0.37
CYP3A4 P08684 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7958687 0.86 TBXA2R (0.50) CA2MCL1HPGDKDM4EALDH1A1
SCHEMBL7956254 0.79 MAPT (0.44) MAPTPKMHTTNPSR1GAA
SCHEMBL7958928 0.78 TBXA2R (0.52) CA2HPGDKDM4EALDH1A1SMN1; SMN2
SCHEMBL7958863 0.76 TBXA2R (0.51) MCL1HPGDKDM4EALDH1A1TBXA2R
SCHEMBL7956738 0.76 TBXA2R (0.51) CA2HPGDKDM4EALDH1A1SMN1; SMN2
SCHEMBL7956160 0.74 ADORA2A (0.42) MAPTPKMHTTGAAADORA3
SCHEMBL7963013 0.69 TBXA2R (0.52) HPGDKDM4EALDH1A1TBXA2RPTGIR
SCHEMBL7948850 0.68 TBXA2R (0.46) HPGDKDM4EALDH1A1SMN1; SMN2TBXA2R
SCHEMBL7958749 0.67 PTGIR (0.55) HPGDKDM4EALDH1A1SMN1; SMN2TBXA2R
SCHEMBL7948722 0.66 TBXA2R (0.56) HPGDKDM4EALDH1A1SMN1; SMN2TBXA2R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6323235-B1 CARDIOVASCULAR DISORDERS, ANTIISCHEMIC AGENTS AND ENZYME INHIBITORS OHTAKE ATSUSHI (JP) 2001-11-27 US disclosed